Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study
Badawi, R., Hussein, B., Watany, M., Elsabagh, H., Elkhalawany, W. (2022). Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study. EKB Journal Management System, 5(1), 58-75. doi: 10.21608/ajgh.2022.153872.1010
Rehab Badawi; Boshra El-sayed Hussein; Mona Mohamed Watany; Hala Moustafa Elsabagh; Walaa Elkhalawany. "Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study". EKB Journal Management System, 5, 1, 2022, 58-75. doi: 10.21608/ajgh.2022.153872.1010
Badawi, R., Hussein, B., Watany, M., Elsabagh, H., Elkhalawany, W. (2022). 'Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study', EKB Journal Management System, 5(1), pp. 58-75. doi: 10.21608/ajgh.2022.153872.1010
Badawi, R., Hussein, B., Watany, M., Elsabagh, H., Elkhalawany, W. Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Cross-Sectional Study. EKB Journal Management System, 2022; 5(1): 58-75. doi: 10.21608/ajgh.2022.153872.1010